Thyrocare Technologies Share Price
Small Cap | Pharmaceuticals and health care | NSE: THYROCARE | BSE: 539871
₹726.75 
7.20 (1.00 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 726.05
High (₹) 734.70
Low (₹) 714.00
Prev. Close (₹) 719.55
Volume 546
VWAP (₹) 722.95
ROCE (%) 18.03
Industry P/E 90.16
TTM P/E 43.91
P/B Ratio 7.28
Market Cap (₹) Cr.3,846.00
Dividend Yield (%)2.48
EPS (₹) 13.40
ROE13.45%
Sales Growth (%) 8.58
Profit Growth (%)9.37
Day Range
734.70734.70
52 Week Range
555.851,053.05
Historical Returns
Returns (6M)
-19.89 %
Returns (1Y)
16.93 %
Returns (3Y)
-16.77 %
Returns (5Y)
23.08 %
Returns (6M)
-19.89 %
Returns (1Y)
16.93 %
Returns (3Y)
-16.77 %
Returns (5Y)
23.08 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (10.38%) TTM EPS Growth
- Company with Low Debt
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 10.38% positive TTM EPS growth
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 42.71
MFI 40.58
ATR 31.46
Commodity Channel Index -79.05
ROC125 -19.06
ROC21 -7.85
Williams %R -75.23
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 736.54 | 745.97 | 757.24 | 725.27 | 715.84 | 704.57 | 695.14 |
| Week Ago | 733.19 | 744.47 | 753.79 | 723.87 | 712.59 | 703.27 | 691.99 |
| Month Ago | 843.84 | 866.22 | 883.14 | 826.92 | 804.54 | 787.62 | 765.24 |
EMA & SMA
726.75
Current Price
Bullish Moving Averages
3
Bearish Moving Averages
17
5 Day 716.99
9 Day 730.48
10 Day 739.35
12 Day 752.57
14 Day 752.18
20 Day 759.09
26 Day 775.74
50 Day 849.83
100 Day 885.73
200 Day 807.54
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| JAINAM SHARE CONSULTANTS PVT. LTD. | bulk | Sell | 20 Jun, 2023 | ₹499.00 | 899 | BSE |
| ARISAIG ASIA CONSUMER FUND LIMITED | bulk | Sell | 20 Jun, 2023 | ₹488.18 | 26,72,707 | BSE |
| JAINAM SHARE CONSULTANTS PVT. LTD. | bulk | Buy | 20 Jun, 2023 | ₹488.83 | 2,70,899 | BSE |
| ICICI PRUDENTIAL MUTUAL FUND | bulk | Buy | 20 Jun, 2023 | ₹488.00 | 7,64,947 | BSE |
| FUNDSMITH EMERGING EQUITIES TRUST PLC | bulk | Sell | 29 Aug, 2022 | ₹615.14 | 3,20,000 | BSE |
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 14 May, 2024 | Rs.18.0000 per share(180%)Final Dividend | 16 Aug, 2024 | 16 Aug, 2024 |
| 10 Apr, 2023 | Rs.18.0000 per share(180%)Interim Dividend | 20 Apr, 2023 | 20 Apr, 2023 |
| 02 May, 2022 | Rs.15.0000 per share(150%)Interim Dividend | 11 May, 2022 | 12 May, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 19 Feb, 2025 | NSE India | The Exchange has sought clarification from Thyrocare Technologies Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. The response of the Company is awaited. |
| 03 Feb, 2025 | NSE India | Updated Limited Review report on the Consolidated Financial results for the quarter and nine months ended December 31, 2024. |
| 03 Feb, 2025 | NSE India | Thyrocare Technologies Limited has informed the Exchange regarding ''Updated Limited Review report on the Consolidated Financial results for the quarter and nine months ended December 31, 2024''. |
| 03 Feb, 2025 | BSE India | The Company has submitted the financial results along with Limited review report for quarter and nine months ended December 31, 2024. It is hereby submitted that due to an inadvertent error during the scanning process, a page containing Points No 4 to 6 of the Limited review report was inadvertently omitted. The corrected Limited Review report is attached herewith. There are no other changes to earlier intimation made on January 23, 2025. |
| 03 Feb, 2025 | BSE India | The Company has submitted the financials results along with Limited review Report for quarter and nine months ended December 31, 2024, It is hereby submitted that due to an inadvertent error during the scanning process, a page containing Points No 4 to 6 of the Limited Review Report was inadvertently omitted. The corrected Limited Review Report is attached herewith. There are no other changes to earlier intimation made on January 23, 2025. |
| 27 Jan, 2025 | BSE India | Please find attached herewith Transcript for earning conference call held on January 23, 2025.\r\n |
| 27 Jan, 2025 | NSE India | Thyrocare Technologies Limited has informed the Exchange about Transcript |
| 25 Jan, 2025 | NSE India | Thyrocare Technologies Limited has informed the Exchange about Copy of Newspaper Publication on Unaudited financial results for the quarter and nine months ended December 31, 2024. |
| 23 Jan, 2025 | NSE India | Thyrocare Technologies Limited has informed the Exchange regarding Allotment of Securities |
| 23 Jan, 2025 | NSE India | THYROCARE TECHNOLOGIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 17 Jan, 2025 | 23 Jan, 2025 |
| Quarterly Results | -- | 17 Oct, 2024 | 23 Oct, 2024 |
| Quarterly Results | -- | 19 Jul, 2024 | 23 Jul, 2024 |
| Audited Results & Final Dividend | -- | 08 May, 2024 | 14 May, 2024 |
| Quarterly Results | -- | 25 Jan, 2024 | 01 Feb, 2024 |
| Quarterly Results | -- | 25 Oct, 2023 | 31 Oct, 2023 |
| Quarterly Results | -- | 27 Jul, 2023 | 01 Aug, 2023 |
| Audited Results | -- | 16 May, 2023 | 23 May, 2023 |
| Interim Dividend | -- | 04 Apr, 2023 | 07 Apr, 2023 |
| Quarterly Results | -- | 18 Jan, 2023 | 03 Feb, 2023 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
|---|
About Thyrocare Technologies
Thyrocare Technologies is a Public Limited Listed company incorporated on 28/01/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85110MH2000PLC123882 and registration number is 123882. Currently Company is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 524.02 Cr. and Equity Capital is Rs. 52.95 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
2000
Managing Director
Mr. Rahul Guha
NSE Symbol
THYROCARE
Thyrocare Technologies Management
| Name | Designation |
|---|---|
| Mr. Rahul Guha | Managing Director & CEO |
| Mr. Dharmil Sheth | Non Executive Director |
| Mr. Hardik Dedhia | Non Executive Director |
| Mr. Dhaval Shah | Non Executive Director |
| Mr. Gopalkrishna Shivram Hegde | Independent Director |
| Dr. Indumati Gopinathan | Independent Director |
| Dr. Neetin S Desai | Independent Director |
| Dr. Prapti Gilada | Independent Director |
| Dr. Harshil Vora | Independent Director |
| Mr. Nishant A Shah | Independent Director |
| Mr. Anandh Sundar | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Max Heal.Ins | ₹1,09,500.95 | ₹1,010.25  ₹1,031.85(-2.09%) | ₹669.650 - ₹1,215.000 |
| Apollo Hspt | ₹1,04,190.68 | ₹6,317.55 ₹6,390.95(-1.15%) | ₹5,639.700 - ₹7,545.100 |
| Fortis Healt | ₹51,495.70 | ₹619.35  ₹609.90(1.55%) | ₹375.100 - ₹740.100 |
| GlobalHealth | ₹29,286.77 | ₹1,235.55 ₹1,206.40(2.42%) | ₹930.000 - ₹1,513.750 |
| Narayana Hru | ₹26,515.81 | ₹1,396.80 ₹1,404.55(-0.55%) | ₹1,087.800 - ₹1,445.050 |
FAQs on Thyrocare Technologies
What is the share price of Thyrocare Technologies?
The share price of Thyrocare Technologies on 21 Feb, 2025 is ₹ 726.75.
What is 52W high and 52W low share price of Thyrocare Technologies?
The highest and lowest 52W share prices of Thyrocare Technologies are ₹ 1050.650 and ₹ 555.850
What is the market cap of Thyrocare Technologies?
The market capitalization of Thyrocare Technologies as of 21 Feb, 2025 is ₹ 3,846.00 Crores
What is the P/E ratio of Thyrocare Technologies?
The current P/E ratio of Thyrocare Technologies as of 21 Feb, 2025 is 90.16
What is the PB ratio of Thyrocare Technologies?
The PB ratio of Thyrocare Technologies as of 21 Feb, 2025 is 7.28
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)